Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:68-76

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Sousa, E.
Right arrow Articles by Ventura-Clapier, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Sousa, E.
Right arrow Articles by Ventura-Clapier, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Animal models of human disease
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Heart failure - basic studies
(Circulation Research. 1999;85:68-76.)
© 1999 American Heart Association, Inc.


Original Contribution

Subcellular Creatine Kinase Alterations

Implications in Heart Failure

E. De Sousa, V. Veksler, A. Minajeva, A. Kaasik, P. Mateo, E. Mayoux, J. Hoerter, X. Bigard, B. Serrurier, R. Ventura-Clapier

From Cardiologie Cellulaire et Moléculaire (E.D.S., V.V., P.M., E.M., J.H., R.V.-C.), U-446 INSERM, Faculté de Pharmacie, Université Paris-Sud, Châtenay-Malabry, France; Unité de Bioénergétique (X.B., B.S.), Centre de Recherches du Service de Santé des Armées, La Tronche, France; and Departments of Pharmacology and Pathological Anatomy (A.M., A.K.), Medical Faculty, Tartu University, Tartu, Estonia.

Correspondence to Renée Ventura-Clapier, Cardiologie Cellulaire et Moléculaire, U-446 INSERM, Université Paris-Sud, Faculté de Pharmacie, 92296 Châtenay-Malabry, France. E-mail renee.ventura{at}cep.u-psud.fr


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—We have tested the hypothesis that decreased functioning of creatine kinase (CK) at sites of energy production and utilization may contribute to alterations in energy fluxes and calcium homeostasis in congestive heart failure (CHF). Heart failure was induced by aortic banding in 3-week-old rats. Myofilaments, sarcoplasmic reticulum (SR), mitochondrial functions, and CK compartmentation were studied in situ using selective membrane permeabilization of left ventricular fibers with detergents (saponin for mitochondria and SR and Triton X-100 for myofibrils). Seven months after surgery, animals were in CHF. A decrease in total CK activity could be accounted for by a 4-fold decrease in activity and content (Western blots) of mitochondrial CK and a 30% decrease in M isoform of CK (MM-CK) activity. In myofibrils, maximal force, crossbridge kinetics, and {alpha}-myosin heavy-chain expression decreased, whereas calcium sensitivity of tension development remained unaltered. Myofibrillar CK efficacy was unchanged. Calcium uptake capacities of SR were estimated from the surface of caffeine-induced tension transient (SCa) after loading with different substrates. In CHF, SCa decreased by 23%, and phosphocreatine was 2 times less efficient in enhancing calcium uptake. Oxidative capacities of the failing myocardium measured as oxygen consumption per gram of fiber dry weight decreased by 28%. Moreover, the control of respiration by creatine, ADP, and AMP was severely impaired. Our observations provide evidence that alterations in CK compartmentation may contribute to alterations of energy fluxes and calcium homeostasis in CHF.


Key Words: mitochondrial respiration • myofibril • compartmentation • sarcoplasmic reticulum • skinned fiber


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The mechanisms underlying the decline in cardiac pump function in heart failure are incompletely understood. They lead to a gradual increase in left ventricular (LV) end diastolic pressure and a decrease in systolic pressure. In the past decade attention has been focused on the alterations of the various steps in excitation-contraction coupling and intracellular calcium homeostasis,1 2 3 whereas the possible involvement of a mismatch in energy supply and demand has received less attention.4 5 6 It has been shown recently that in human heart failure, there is a generalized alteration of the creatine kinase (CK) system with a decrease in total enzyme activity and velocity and alteration in the isoenzyme pattern, which could contribute to the pathogenesis of heart failure.5 Moreover, in patients with dilated cardiomyopathy, the phosphocreatine (PCr)/ATP ratio, governed by CK activity, may be a predictor of both total and cardiovascular mortality.7 However, the precise cellular mechanisms by which altered CK may compromise energy fluxes and contractility are not well understood.

CK is an important enzyme involved in energy maintenance and energy transfer in muscle and brain cells. It catalyzes the reversible transfer of a phosphate moiety between ATP and creatine. Four different isoforms of CK are expressed in a tissue-specific and developmentally regulated manner. A major part of muscle CK exists as dimers composed of 2 subunits, M and B, giving 3 isoenzymes, MM, BB, and MB. In addition, there is a fourth isoenzyme in the mitochondria (sarcomeric mitochondrial CK [mi-CK]), which differs biochemically and immunochemically from the cytosolic forms and can form both octameric and dimeric structures.8 In muscle cells, reactions involved in ATP generation and utilization are not governed by stochastic events, but rather occur within structural and functional entities and are spatially and temporarily coordinated. CK isoenzymes are not evenly distributed in the cardiac cell, but the CK system constitutes an example of a compartmentalized metabolic pathway. MM-CK has been found in myofibrils and described as a structural protein of the M band participating in the connections between myosin filaments inside muscle fibers.9 This bound MM-CK is functionally coupled to the myosin ATPase and can provide enough energy to sustain maximal force and normal kinetics of contraction (for review, see Reference 1010 and references therein). Similarly, MM-CK is strongly bound to sarcoplasmic reticulum (SR) membranes, in which it is functionally coupled to the Ca2+-ATPase, and ensures efficient energy provision of the SR by the local regeneration of ATP.11 12 13 14 mi-CK is found on the outer surface of the inner mitochondrial membrane, in the vicinity of the ATP-ADP carrier, so that ATP generated by oxidative phosphorylation, after transport through the inner mitochondrial membrane, is transphosphorylated to PCr (for review, see References 15 and 1615 16 and references therein). The sites of energy production and energy utilization are integrated through near-equilibrium reactions of CK in the cytosol, promoting sequential equilibration that results in almost instantaneous transfer of phosphoryl groups and metabolic signal.8 16 It is conceivable that altered compartmentation of the CK isoenzymes in congestive heart failure (CHF) may impair the functioning of intracellular compartments, thus compromising integration between energy production and utilization.

The goal of this study was to investigate the role of bound CK isoforms on the intrinsic functional properties of the 3 main intracellular cardiac compartments involved in excitation-contraction coupling (myofibrils and SR) and energy production (mitochondria) and their alterations in heart failure. Using an animal model of prolonged chronic heart failure induced by aortic banding, we examined (1) whether the function of these cellular compartments is altered in heart failure, (2) whether alterations in localized CK isoforms may alter the regulation and function of these subcellular compartments, and (3) how these alterations may contribute to the pathophysiology of heart failure.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Rat Model of CHF
Male Wistar rats were randomly assigned to 1 of 2 groups, the CHF or the sham-operated group.

After induction of anesthesia with intraperitoneal injection of pentobarbital (60 mg/kg), aortic stenosis was created in weaned male rats (60 to 70 g) by placing a stainless steel hemoclip of 0.6-mm ID on the ascending aorta via a thoracic incision (CHF group).17 Age-matched controls underwent the same procedure without placement of the clip (sham group). All rats were fed a normal chow diet and water ad libitum with a 12-hour/12-hour photoperiod. This investigation was carried out in accordance with the Helsinki Recommendations for Humane Treatment of Animals during Experimentation.

Seven months after surgery, mortality was {approx}70% in the CHF group, and 13 CHF rats and 15 sham rats were studied. Animals were anesthetized with an intraperitoneal injection of urethane (0.2 g/100 g). Right and left ventricles were isolated and weighed. Parts of the left ventricles were rapidly frozen in liquid nitrogen for biochemical and morphological determinations, and other parts were immediately used for respiration or mechanical experiments. Additionally, lungs, kidneys, and liver were blotted and weighed. Left tibia length was measured.

To confirm the existence of heart failure, the mechanical function was assessed in Langendorff-perfused hearts of the sham and CHF groups (n=4). Hearts were retrogradely perfused with Krebs Henseleit solution containing 10 mmol/L glucose as substrate and 1.75 mmol/L CaCl2. The flow per gram wet weight (ww) was kept constant in both series (8 mL/min per gram ww). Hearts were stimulated at 240 bpm. A balloon, inserted in the left ventricle, was progressively inflated to reach the plateau of the pressure/volume relationship (the volume required was 240 µL in CHF and 260 µL in sham). LV developed pressure (LVDP) and LV end diastolic pressure (LVEDP) were analyzed online. The "arterial" PO2 (PaO2) just above the aorta and "venous" PO2 (PvO2) in the pulmonary artery were measured online through 2 flow cells, Clark electrodes, and an oxymeter (Stratkhelvin Institute). The oxygen consumption (PaO2–PvO2) was expressed in µmol O2/min per gram ww (QO2).

Morphological and Biochemical Studies
Collagen was quantified using a histological method. Cryosections of left ventricle were exposed to hematoxylin and then to acid fuchsin according to the van Gieson method. Three or four areas of each transverse section representative of the left ventricle were magnified, and video images of the section were digitized (Visiolab 200 image-processing system, Biocom).

Frozen tissue samples were weighed; homogenized in ice-cold buffer (50 mg/mL) containing (in mmol/L) HEPES 5 (pH 8.7), EGTA 1, DTT 1, and MgCl2 5, and 0.1% Triton X-100; and incubated for 60 minutes at 0°C to ensure complete enzyme extraction. The total activities of adenylate kinase (AK), CK, pyruvate kinase (PK), phosphoglycerate kinase (PGK), and lactate dehydrogenase (LDH) were assayed (30°C, pH 7.5) using coupled enzyme systems as previously described.18 19

CK isoenzymes were separated using agarose (1%) gel electrophoresis performed at 200 V for 90 minutes; individual isoenzymes were resolved by incubating the gels with a coupled enzyme system.19 Internal standards of commercial MM-CK were run in parallel with tissue samples to ensure linearity in isoenzyme quantification. To avoid saturation of the various CK isoform signals, 3 dilutions were run for each sample. Isoenzyme bands were visualized by the fluorescence of NADPH. The LDH isoenzyme profile was determined using agarose gel electrophoresis (Sigma LDH reagent kit) at 200 V for 90 minutes. Gels were quantified using an image-analysis system (Bio-Rad). Activity of CK and LDH isoenzymes was quantified by multiplying each percentage by total activity, as determined spectrophotometrically. Determination of citrate synthase activity was performed according to Srere.20 Protein concentration was determined with the Lowry method, using BSA as a standard.

Native myosin was extracted from frozen tissues according to d'Albis et al.21 Myosin isoforms were separated by PAGE. Gel-running buffer consisted of 20 mmol/L sodium pyrophosphate (pH 8.5), 10% glycerol, 0.01% 2-mercaptoethanol, and 2 mmol/L MgCl2. Cylindrical (6x0.5-cm) gels contained 4% polyacrylamide (3.88% acrylamide and 0.12% N,N'-methylene-bis-acrylamide). Between 1 and 5 µg of myosin was loaded on each gel. Electrophoresis was carried out at a constant voltage of 90 V, for 22 hours, between 2°C and 4°C.22

Western Blot Analysis
Protein extracts (1 and 4 µg) from sham and CHF hearts and from 1 control and 1 mi-CK knockout mouse23 heart were separated on 12% SDS-polyacrylamide gels and subsequently transferred to Hybond nitrocellulose membranes (Amersham). Mouse mi-CK antibody (a kind gift of Drs Z. Khuchua and W. Qin, Washington University, St Louis, Mo) was produced in rabbit anti-mouse whole recombinant sarcomeric mi-CK. The membranes were incubated with the mi-CK antibody for 2 hours. After washing, the membranes were incubated with horseradish peroxidase anti-rabbit IgG secondary antibody for 90 minutes and revealed with enhanced chemiluminescent substrate (ECL+ kit, Amersham). Light emission was detected by autoradiography and quantified using an image-analysis system (Bio-Rad). Only 1 band of the appropriate size (43 kDa) was obtained, and no signal was obtained with the cardiac extract from the mi-CK knockout mouse, which demonstrates the high specificity of the antibody.

Functional Properties of Mitochondria and Bound CK and AK
Respiratory parameters of the total mitochondrial population were studied in situ in saponin-skinned fibers, as previously described.24 Briefly, thin fiber bundles (100 to 250 µm in diameter) were excised from the endocardial wall of the left ventricle and incubated for 30 minutes at 4°C in solution S (see below) containing 50 µg/mL saponin to permeabilize the sarcolemma. Respiratory rates were determined using a Clark electrode (Strathkelvin Instruments) in an oxygraphic cell containing 3 mL of solution R (see below) at 22°C with continuous stirring. The solubility of oxygen was {approx}230 nmol of O2/mL in buffer after standard calibration in water. After measurements, the fiber bundles were carefully removed and dried. Respiration rates were expressed as µmol O2/min per gram dry weight. Solutions S and R contained (in mmol/L) EGTA–calcium-EGTA buffer 10 (free Ca2+ concentration, 100 nmol/L), MgCl2 1, taurine 20, DTT 0.5, imidazole 20, and ionic strength 160 (potassium methanesulphonate).24 25 In addition, solution S (pH 7.1) contained 5 mmol/L MgATP and 15 mmol/L PCr, and solution R (pH 7.1) contained (in mmol/L) glutamate 5, malate 2, and phosphate 3, and 2 mg/mL fatty acid–free BSA. Functional activity of mi-CK in skinned fibers was assessed by the determination of ADP kinetic parameters in the presence (20 mmol/L) or absence of creatine. The ADP-stimulated respiration (VADP) above basal oxygen consumption (V0) was plotted as a function of [ADP]. The apparent Michaelis-Menten constants (Kms) for ADP and VADP were calculated using a nonlinear fitting of the Michaelis-Menten equation. Maximal respiration rate (Vmax) was (VADP+V0). Acceptor control ratio was calculated as Vmax/V0. The functional activity of AK was evaluated by the percentage increase in the respiration rate after addition of 2 mmol/L AMP in the presence of 0.2 mmol/L ATP (VAMP%). One to three determinations were made for each animal.

Mechanical Experiments
Muscle fiber bundles were dissected from papillary muscles of the left ventricle in a zero-Ca2+ Krebs solution (pH 7.4) and incubated for 1 hour in a relaxing solution (pCa 9; see solutions below) containing 1% Triton X-100 to solubilize the membranes. Bundles were mounted between a vibrator and a force transducer (model AE 801, SensoNor Microelectroniks) as previously described.18 Sarcomere length was measured by laser diffraction and adjusted to 2.1 to 2.2 µm. Muscles were immersed in 2.5-mL chambers continuously stirred at high speed (22°C). Solutions were prepared according to Fabiato26 as previously described27 and contained (in mmol/L) EGTA 10, imidazole 30 (pH 7.1), Na+ 30.6, Mg2+ 3.16, and DTT 0.3, with acetate as anion. Ionic strength was adjusted to 160 mmol/L with potassium acetate. pCa was 9 in relaxing and rigor solutions and 4.5 in activating solution. Relaxing and activating solutions also contained 3.16 mmol/L MgATP and 12 mmol/L PCr. Rigor solutions were obtained by mixing 2 solutions of pMgATP 2.5 and 6 (without 12 mmol/L PCr) or pMgATP 4 and 6 (with PCr). pCa (or pMgATP)/tension relationships were determined under isometric conditions by stepwise changes in calcium or MgATP concentrations until maximal tension was reached. Data were fitted using a nonlinear fit of the Hill equation, as follows: T=Ln/(K+Ln), where L is the ligand concentration (ATP or Ca2+), T is the relative tension, K is a constant, and n is the Hill coefficient. Slope coefficient n and pL for half-maximal activation (pL50=-log10K/n) were calculated for each bundle by means of nonlinear regression analysis. To determine the rate constant of tension recovery, quick length changes (0.3% to 3% of initial muscle length) were applied in the relaxing and activating solutions, as previously described.18 The rate constant of tension recovery after quick stretches was calculated by a least-squares regression analysis, according to a single-exponential model, between 50% and 80% of recovery and using stretches of >1%.

Estimation of Ca2+ Loading by SR
The technique for assessing SR function using caffeine-induced tension transient in saponin-skinned fibers was a modified version of the one described previously14 in the same experimental setup as for mechanical experiments. Experiments were performed at 22°C in solutions containing (except otherwise stated) (in mmol/L) EGTA 10; BES 60 (pH 7.1), Na+ 30.6, Mg2+ 0.8, DTT 0.3, sodium azide 2, leupeptin 0.02, ionic strength 160 (potassium methanesulphonate), MgATP 3.16, and PCr 12, with varying amounts of calcium.

After emptying the SR by brief application of caffeine (5 mmol/L), loading was carried out in strongly buffered (10 mmol/L EGTA) loading solutions at pCa 6.25. Each fiber was randomly loaded for 10, 30, 60, 180, and 420 seconds in the presence of either MgATP+PCr (control load) or ATP alone (ATP load). To assess efficacy of glycolysis in supporting calcium uptake, SR was loaded for 420 seconds in the presence of (in mmol/L) MgADP 1+NAD+ 4+glyceraldehyde 3-P 6+Pi 2 (glycolytic load), which allows activation of the 2 ATP-generating steps of glycolysis, PGK and PK.

The caffeine-induced tension transient was used to calculate the time course of free [Ca2+] close to myofibrils during the release, taking the pCa/tension dependence as internal calibration, as previously described.14 For this purpose, the pCa/tension relationship in the presence of 5 mmol/L caffeine was obtained at the end of each experiment, and tensions were normalized with respect to the maximal calcium-activated tension. The data from each fiber were fitted to the Hill equation, and the [Ca2+] at each step of the tension-time integral was recalculated using Labview software (National Instruments Corp) to obtain [Ca2+]xtime integrals (SCa), which were taken to evaluate the SR Ca2+ loading capacity.

Statistical Analysis
The data are expressed as mean±SEM. A Student t test was used to determine the statistical difference of means between the sham and CHF groups. A paired t test was used to compare tension and calcium-time integral obtained in different substrates within each group. SCa values were analyzed by ANOVA using a 2 (load)x2 (condition [sham or CHF])x5 (time) factorial design with repeated measures. When a significant F ratio was found, a Newman-Keuls test was used to detect differences between groups. Values of P<0.05 were considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Anatomical and Functional Data
Anatomical data are summarized in Table 1Down. CHF animals showed decreased body weight (–29%) and increased heart weight (+90%). Expressed per tibia length, heart weight (+118%), left (+91%) and right (+117%) ventricular weights, and lung (+100%) weight were all significantly increased. Moreover, obvious clinical evidence of cardiac decompensation (brown and "nutmeg" liver, ascites, pleural effusions, enlarged atria, lethargy and dyspnea, or left atrial thrombi) was observed in all CHF rats.


View this table:
[in this window]
[in a new window]
 
Table 1. Characterization of CHF Rats Compared With Sham

Experiments with isolated perfused hearts confirmed that CHF hearts exhibit systolic and diastolic abnormalities that characterize heart failure (Table 1Up). LVDP was not different between the 2 groups but decreased by 39% when normalized per grams of left ventricle. LVEDP was significantly higher in CHF than in sham rats. This was associated with a 28% decrease in QO2.

Biochemical Data
Enzyme activities are presented in Table 2Down. The total protein content of CHF myocardium was slightly lower and interstitial collagen was higher in CHF myocardium, evidencing signs of edema and increased fibrosis with broad variations from heart to heart. Enzyme activities were thus reported per mg protein using the Lowry method, which minimizes the contribution of aromatic amino acid residues abundant in collagen.28 The activity of AK, a phosphotransfer enzyme, was unchanged in CHF. LDH activity was also unchanged in CHF myocardium, but the proportion of the cardiac aerobic subunit (H-LDH) was significantly decreased. PK and PGK, the 2 steps of glycolytically produced ATP, were decreased as well in CHF. Citrate synthase activity, a marker of mitochondrial capacities or mitochondrial mass, was decreased by 33%.


View this table:
[in this window]
[in a new window]
 
Table 2. Enzymatic Activities in Left Ventricle of CHF Rats Compared With Sham

CK System
CK activity and isoenzyme profile, whether expressed as IU/mg protein or as percentage of total CK activity, were greatly affected in CHF rats (Table 3Down). Total CK activity was reduced by 45%, with great differences among the 4 isoenzymes. Although the relative proportion of the B isoform of CK (BB-CK) increased in CHF myocardium (+136%), the activity was maintained, as was the activity of the B-subunit (BB-CK+1/2MB). Activity of MM-CK and the heterodimer of B and M CK (MB-CK) exhibited a 30% to 40% decrease. The most dramatic change was an 83% decrease in the mi-CK isoform. This decrease exceeded the overall decrease in mitochondrial activity, since the mi-CK to citrate synthase ratio exhibited a 4-fold decrease. Western blot analysis of mitochondrial CK protein (Figure 1Down and Table 3Down) showed that this decrease could be entirely accounted for by a decrease in mi-CK protein content with no change in the enzyme specific activity.


View this table:
[in this window]
[in a new window]
 
Table 3. CK System in Left Ventricle of CHF Rats Compared With Sham



View larger version (65K):
[in this window]
[in a new window]
 
Figure 1. Mitochondrial CK content in left ventricle of CHF and sham rats. Representative Western blot analysis of sham and CHF rat LV homogenates probed with mi-CK antibody. Tissues were homogenized in low–ionic strength pH 8.7 buffer, and 1 or 4 µg of proteins per lane were electrophoresed on 12% SDS-polyacrylamide gels. To check antibody specificity, ventricular homogenates of 1 control mouse (mi-CK+/+) and 1 mi-CK–knockout mouse (mi-CK-/-) were added. After blotting, membranes were incubated with primary antibody against mi-CKs for 2 hours. After incubating the membranes with horseradish peroxidase–labeled secondary antibody, they were revealed with ECL+ chemiluminescent substrate. Light emission was detected by autoradiography and quantified using image analysis. Only 1 band of the appropriate size was observed (43 kDa). A clear decrease in mi-CKs proteins is seen in CHF rat hearts. No band was observed for the homogenate of the mi-CK-/- mouse.

Mitochondrial Function and CK
To establish the functional consequences of the decrease in mi-CK on mitochondrial regulation, oxygen consumption of permeabilized preparations from control (sham) and experimental (CHF) rats was recorded as a function of ADP concentration (Figure 2Down) in the absence or in the presence of creatine. As ADP concentration increased, respiration rate reached a plateau that was significantly lower in failing than in control hearts. The addition of creatine shifted the relationship toward lower ADP concentrations, both in sham and CHF, although to a lesser extent in the latter. The relationship between respiration rate and ADP concentration could be reasonably fitted by the Michaelis-Menten equation. The averaged results are presented in Table 4Down. Maximal and basal respiration rates showed a {approx}30% reduction, which suggests a decrease in oxidative capacities in CHF. As the acceptor control ratio was high and preserved in CHF, this decrease suggested a decreased amount of mitochondria without changes in the oxidation-phosphorylation coupling. Indeed, reduced respiration correlated to reduced mitochondrial content assessed by citrate synthase activity. In the absence of creatine, the Km for ADP was significantly higher in CHF than in sham. After addition of creatine, the decrease in Km for ADP (CK efficacy) was less in CHF (2.3 times) than in sham (4 times). The stimulation of respiration by AMP in the presence of ATP was 70% in sham and only 45% in CHF (P=0.02), which shows an impairment of mitochondrial AK efficacy as well.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Regulation of mitochondrial respiration by ADP and creatine in LV of CHF and sham rats. ADP dependence of mitochondrial respiration in representative saponin-skinned ventricular fibers from sham ({square}) and CHF ({circ}) rats in the absence (A) and in the presence (B) of creatine is shown. Oxygen consumption rates (O2) were measured using a Clark electrode with glutamate and malate as substrates and were plotted as a function of ADP concentration. Data were fitted using a Michaelis-Menten equation to obtain Km and Vmax (maximum ADP-stimulated respiration) values (dotted and solid lines, respectively). VADP was lower in CHF than in sham. The presence of creatine resulted in an increased affinity of mitochondria for ADP, with no change in VADP. However, creatine was less effective in CHF than in sham.


View this table:
[in this window]
[in a new window]
 
Table 4. Mitochondrial Function in Saponin-Treated LV Fibers of CHF Rats Compared With Sham

It thus appeared that both the maximal capacities and the regulation of mitochondria were altered in CHF.

SR Function and CK
The function of the SR was studied in saponin-skinned fibers loaded with Ca2+ for different periods of time and emptied by the application of 5 mmol/L caffeine. The tension transients were used to estimate calcium uptake and release properties of the SR of sham and CHF myocardium. Because the calcium sensitivity of tension development in the presence of caffeine was higher in CHF (pCa50=5.824±0.012) than in sham (5.776±0.012, P=0.017), the [Ca2+]xtime integral (SCa) was recalculated from tension transients by using the calcium sensitivity of tension development for each fiber to minimize any difference caused by myofilament properties.14 SCa reflects the amount of calcium released by the SR and reaching myofilaments. SCa was plotted as a function of the loading time in sham (Figure 3ADown) and CHF (Figure 3BDown). When MgATP was the only substrate, SCa increased slightly with time. There was no difference between sham and CHF. When PCr was added in sham, SCa increased sharply, reaching a 3.2 times higher value for a 420-second load than with MgATP alone. In CHF (Figure 3BDown), for a 420-second load, SCa was 23% lower than in sham in the presence of both substrates (41.0±4.1 µmol/Lxseconds in sham versus 31.7±3.2 µmol/Lxseconds in CHF, P=0.01). It appeared, therefore, that the addition of PCr enhanced calcium uptake to a much lower extent in CHF (Figure 3CDown). For a 420-second load, PCr increased SCa 3.2 times in sham but only 2.4 times in CHF (P=0.004) (CK efficacy). To investigate whether ATP supplied by bound glycolytic enzymes could provide energy for calcium uptake and whether this was altered in CHF, SR was loaded in the presence of glycolytic substrates (6 mmol/L glyceraldehyde 3-P with 1 mmol/L MgADP, 4 mmol/L NAD+, and 2 mmol/L Pi). A 420-second load resulted in a SCa reaching 107±6% of that in the presence of ATP alone and was not significantly affected in CHF (103±9%) (data not shown). This finding also shows that PGK and possibly PK are present and active close to SR ATPase in skinned fibers. It thus appeared that one main alteration in SR function in CHF was the inability of bound CK to support calcium uptake.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Energy dependence of calcium loading in LV of CHF and sham rats. Parameters of caffeine-elicited tension transient were plotted as a function of loading time in the presence of 3.16 mmol/L MgATP without ({blacksquare}) or with (•) 12 mmol/L PCr for sham (A) or CHF (B) rats. Tension transients were recalculated by using the pCa/tension relationship as an internal calibration of calcium release (see Materials and Methods) and integrated over time. [Ca2+]xtime integrals (SCa) were not different between sham and CHF with ATP as substrate but were significantly lower in CHF when PCr was added to the loading solution. When the increase in SCa after the addition of PCr was plotted as a function of time (C), PCr appeared much more efficient in sham ({square}) than in CHF ({circ}) at increasing calcium loading. *Statistically different from ATP (P<0.05); +statistically different from sham (P<0.05); and **statistically different from sham (P<0.01).

Myofibrillar Function and CK in Left Ventricles of CHF Rats
Myofibrillar function was studied in Triton X-100–treated LV fibers. Averaged results are listed in Table 5Down. Fibers of similar diameters were obtained from sham and CHF myocardium. Active tension development was 24% lower in CHF (P=0.007) than in sham. However, the sensitivity of tension development to calcium was unchanged. The rate constant of tension changes after quick stretches, reflecting the crossbridge cycling rate, was decreased 2.2 times in CHF. This was accompanied by a sharp decrease in the proportion of the fast cardiac {alpha}–myosin heavy chain isoform. In the absence of calcium, a progressive decrease in MgATP concentration leads to the development of rigor tension. The half-maximal MgATP concentration for rigor tension development was shifted toward much lower values in the presence of PCr because of rapid rephosphorylation of ADP by bound CK in the vicinity of myosin ATPase. PCr decreased the ATP50 values to a similar degree in fibers from CHF and sham, showing that myofibrillar CK efficacy was well preserved in CHF myocardium.


View this table:
[in this window]
[in a new window]
 
Table 5. Myofilament Data of LV Triton-Skinned Fibers From CHF and Sham


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
This study examined whether CK system alterations may contribute to altered energy fluxes and contractile dysfunction in heart failure. We investigated the intrinsic functional properties of 3 intracellular compartments involved in energy production (mitochondria) and excitation-contraction coupling (myofibrils and SR). Next, we examined whether alterations in the functional coupling between CK isoenzymes and local ATP and ADP concentrations can compromise these subcellular functions. The results show the following: (1) MM and mi-CK isoenzymes are primarily affected in CHF, with mitochondrial CK exhibiting a dramatic decrease in activity and protein content; (2) the oxidative capacity of cardiac fibers and the control of mitochondrial respiration by phosphate acceptors (creatine, ADP, and AMP) were depressed; (3) SR calcium uptake capacities were preserved when ATP was the substrate, whereas the ability of bound CK to stimulate SR calcium uptake was depressed; and (4) the ability to develop force was decreased in CHF, but calcium sensitivity and myofibrillar CK ability to relax rigor tension were preserved. These results show that local disturbances in energy fluxes may compromise the fine tuning between energy supply and utilization, as well as excitation-contraction coupling.

Alterations in CK System in Heart Failure
This study shows that, as in human heart, CK activity is largely depressed in severe CHF in rats, and that this decrease mainly affects mitochondrial CK activity and MM-CK. AK (another phosphotransfer enzyme) and LDH activities were not affected, which shows that the CK alterations were rather specific. Moreover, we show that the 4-fold decrease in mi-CK activity was entirely accounted for by a decrease in the mi-CK protein content that largely exceeded the decrease in mitochondrial mass. Failure to observe consistent alterations in CK activity or enzymes in animal models of heart failure29 30 31 32 may thus be due to the severity and/or duration of the disease. Indeed, our results agree with the results obtained in end-stage heart failure in humans,5 with the exception that MB-CK, which was decreased in rats, increased 7 times in humans. The maintained MB-CK activity and the less dramatic decrease in M- and particularly mi-CK in human heart may reflect the beneficial effect of pharmacological treatments on the expression of the CK system in humans. For example, long-term treatments by ß-blockers can prevent the decrease in creatine and CK in an animal model of heart failure.33

During hypertrophy and failure, the decrease in mi-CK and mitochondrial content could represent the reactivation of a fetal gene program that is characterized by increased ß-myosin heavy chain, atrial natriuretic factor, and B-CK expression. However, although B-CK expression could represent an adaptive mechanism to a decrease in high-energy phosphates,4 decreased mi-CK content and/or efficacy has been consistently observed in animal models of cardiomyopathies of different origin and is suggested to be a marker of the transition between compensatory hypertrophy and failure (see References 34 and 3534 35 for review and references therein). Signals involved in cardiac remodeling are not yet fully understood. Among them, numerous hormones (eg, angiotensin and epinephrine) and cytokines (eg, tumor necrosis factor-{alpha}), as well as mechanical factors (eg, stretch), have been implicated in the cardiac growth response. The signal transduction pathways could involve protein kinase C and mitogen-activated protein kinase activation, as well as the recently identified calcineurin pathway.36 More work is needed to identify the factor(s) responsible for energy deficiency in heart failure.

Myofibrillar Function and CK in Heart Failure
The contractile dysfunction that was observed in CHF (ie, increased LVEDP and decreased LVDP per gram) may be caused by intrinsic alterations in contractile proteins. The decrease in maximal force reflects an overall decrease in the ability of the myocardial tissue to develop force and could be due to a decrease in contractile proteins or a disorganization of the myofilament structure. Such a decrease was not observed in compensated pressure overload.37 In CHF, no change in calcium responsiveness was observed except in the presence of caffeine, as was previously observed in compensated hypertrophy.37 38 The decrease in the rate constant of tension changes reflects the decrease in the relative amount of the fast myosin isoenzyme generally observed in pressure overload in rat heart.39 However, in CHF, despite a 30% decrease in total activity, MM-CK bound to myofibrils was still able to induce a 54-fold decrease in the ATP50 for relaxation of rigor tension (Table 5Up). The stability of myofibrillar CK could be due to the fact that MM-CK is an integral part of the myofibrillar structure, forming intermyosin bridges in the M line.9 On the other hand, it could be argued that the more economic contractile behavior of pressure-overloaded myocardium40 due to decreasing amount of the fast myosin isoform could be adequately supplied by a lowered amount of MM-CK. It can be concluded that despite altered myofibrillar function, the myofibrillar CK efficacy is preserved in CHF.

Mitochondrial Function and CK
Few data are available concerning the oxidative capacities of the failing heart. Skinned fiber studies of mitochondrial respiration offer the unique opportunity to assess intrinsic oxidative capacities in muscles with nonlimiting amounts of substrates and oxygen. In CHF rats, we observed a 30% decrease in both basal and maximal respiration rates paralleled by a 33% decrease in citrate synthase activity, which suggests a decrease in the amount of mitochondria with preserved coupling between oxidation and phosphorylation. This was accompanied by a decrease in the relative proportion of the cardiac form of LDH and decreased glycolytic ATP-regenerating steps. Decreased oxidative capacities may explain the lower oxygen consumption rate observed in isolated hearts. As the heart utilizes 80% to 90% of its maximum oxidative capacities during exercise,41 decreased aerobic capacities could by themselves limit the ATP synthesis and contractile capacities of the failing heart and contribute to the limited exercise capacity in heart failure.

Cardiac mitochondria maintained within the cellular architecture exhibit regulatory properties that greatly differ from isolated mitochondria.16 This is characterized by a low sensitivity of mitochondrial respiration for extramitochondrial ADP, whereas creatine addition decreases the apparent Km for ADP because of functional coupling between oxidative phosphorylation, translocase, and mi-CK.16 Such a coupling has also been described for mitochondrial AK.42 Regulation of mitochondrial respiration by mitochondrial kinases provides a specialized system by which different cytosolic metabolic pathways linked to cytosolic kinases are connected to mitochondrial respiration.43 44 45 These phosphotransfer systems may provide an efficient integration between energy utilization and production within oxidative tissues. In situ mitochondria from CHF rats appeared 26% less sensitive to ADP, 58% less sensitive to creatine, and 36% less sensitive to AMP (Table 4Up) than mitochondria from sham, showing a loss of regulation of oxidative phosphorylation by phosphate acceptors. This suggests a generalized loss of integration between cytosolic signals and mitochondria in CHF, which could be responsible for altered energy fluxes and incapacity of the failing myocardium to adapt energy production to energy utilization and to mobilize contractile reserve.6

SR Function and CK in Heart Failure
A crucial alteration in SR function was that the increase in calcium uptake brought about by addition of PCr in the presence of ATP was lower in CHF than in sham (Figure 3Up). This is the first demonstration of a possible alteration in SR function by decreased efficacy of bound CK. The decreased efficacy may be attributed to decreased amount of bound MM-CK in SR or disorganization of SR architecture, leading to looser coupling between Ca2+-ATPase and CK.

It is generally assumed that a defect in the capacity of the SR to accumulate calcium participates in the pathophysiology of heart failure. Changes in expression of the different proteins involved in calcium uptake and calcium release by the SR has received much attention, and there is evidence that Ca2+ ATPase is down-regulated in the CHF model used in this study.17 However, efficiency of the calcium pump also depends on adequate energy supply and effective withdrawal of the end products of ATP hydrolysis. Indeed, ATP and ADP exert a kinetic (through affinity and inhibition constants) as well as thermodynamic (through free energy of ATP hydrolysis) control on calcium uptake. A functional coupling between SR Ca2+ ATPase and bound CK allows the maintenance of a high ATP/ADP ratio in the close vicinity of the catalytic site, an adequate energy supply, and relief of product inhibition on the ATPase,11 12 13 thus markedly enhancing the calcium uptake capacity of the SR.14 Implication of MM-CK in kinetics and amplitude of the calcium transient was recently underscored in skeletal muscle of mice deficient in MM-CK46 and in CK-inhibited rat hearts.47

CK System and Heart Failure
The pathogenesis of heart failure is as yet not clearly defined, and the two main hypotheses so far put forward are (1) inadequate calcium uptake and release and (2) mismatch between energy production and utilization. However, these 2 cellular events are closely interrelated. Calcium withdrawal depends on efficient energy-driven calcium pumps and, secondarily, sodium pumps, whereas calcium concentration determines energy expenditure through cellular ATPases. Each of these steps depends on the subcellular architecture and protein organization. Increasing evidence also supports the proposal that localized control of energy fluxes influences calcium homeostasis and contractility. Disturbances in one of these finely controlled cellular processes will make the myocyte enter a vicious cycle of energy mismatch and calcium dysregulation, especially in periods of increased workload.

An alteration in energy metabolism in CHF was demonstrated by (1) decreased oxidative capacity, (2) altered glycolytic pathway, (3) altered expression of the CK system, (4) altered regulation of mitochondrial respiration by phosphate acceptors, and (5) decreased control of localized energy fluxes by bound CKs in mitochondria and SR. Moreover, whole-organ enzymology of the CK system, studied by nuclear magnetic resonance spectroscopy, showed that substrates of the CK reaction were altered in heart failure and that the capacity for ATP resynthesis was 83% lower in failing than in control myocardium.5 48 In normal heart, the fine integration between energy utilization and energy production is produced by functional coupling in which a locally increased ADP is quickly rephosphorylated and the amplified signal is transmitted through the cytosolic energy transfer systems (CK and AK) to mitochondria, where it can stimulate respiration.16 45 In CHF, this fine regulation is impaired, leading to mismatch between synthesis and utilization of energy, and the decreased PCr/ATP ratio7 most probably reflects the chronic imbalance between ATP supply and demand. Decreased efficacy of SR-bound CK to control adenine nucleotides in the vicinity of SR Ca2+ ATPase could contribute to the slowing of calcium uptake and twitch relaxation and to increased diastolic calcium concentration in CHF.49 50 51


*    Acknowledgments
 
R.V.-C. is supported by Centre National de la Recherche Scientifique. A. Kaasik was supported by a Federation of European Biochemical Societies grant. This work was supported by a Programme de Recherche en Santé grant from INSERM. The help of Dr D. Charlemagne with Western blot analysis is warmly acknowledged. The authors thank R. Fischmeister for continuous support, P. Lechêne for engineering assistance, and F. Lefebvre for technical assistance.

Received February 1, 1999; accepted April 21, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. de Tombe PP. Altered contractile function in heart failure. Cardiovasc Res. 1998;37:367–380.[Abstract/Free Full Text]

2. Phillips RM, Narayan P, Gomez AM, Dilly K, Jones LR, Lederer WJ, Altschuld RA. Sarcoplasmic reticulum in heart failure: central player or bystander? Cardiovasc Res. 1998;37:346–351.[Free Full Text]

3. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 1998;37:279–289.[Free Full Text]

4. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation. 1993;87(suppl VII):VII58–VII62.

5. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996;94:1894–1901.[Abstract/Free Full Text]

6. Liao RL, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy: relationship to contractile performance. Circ Res. 1996;78:893–902.[Abstract/Free Full Text]

7. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96:2190–2196.[Abstract/Free Full Text]

8. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure, and function of creatine kinase isoenzymes in tissues with high, and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochem J. 1992;281:21–40.

9. Wallimann T, Eppenberger HM. Localization and function of M-line-bound creatine kinase M-band model and creatine phosphate shuttle. Cell Muscle Motil. 1985;6:239–285.[Medline] [Order article via Infotrieve]

10. Ventura-Clapier R, Veksler V, Hoerter JA. Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem. 1994;133:125–144.

11. Levitskii DO, Levchenko TS, Saks VA, Sharov VG, Smirnov VN. Functional coupling between Ca2+-ATPase and creatine phosphokinase in sarcoplasmic reticulum of myocardium. Biochimyia. 1977;42:1766–1773.

12. Rossi AM, Eppenberger HM, Volpe P, Cotrufo R, Wallimann T. Muscle-type MM creatine kinase is specifically bound to sarcoplasmic reticulum and can support Ca2+ uptake and regulate local ATP/ADP ratios. J Biol Chem. 1990;265:5258–5266.[Abstract/Free Full Text]

13. Korge P, Byrd SK, Campbell KB. Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca2+ ATPase. Eur J Biochem. 1993;213:973–980.[Medline] [Order article via Infotrieve]

14. Minajeva A, Ventura-Clapier R, Veksler V. Ca2+ uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine kinase. Pflügers Arch. 1996;432:904–912.

15. Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta. 1992;1102:119–166.[Medline] [Order article via Infotrieve]

16. Saks VA, Khuchua ZA, Vasilyeva EV, Belikova OY, Kuznetsov AV. Metabolic compartmentation and substrate channeling in muscle cells: role of coupled creatine kinases in in vivo regulation of cellular respiration: a synthesis. Mol Cell Biochem. 1994;133:155–192.

17. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184–192.[Abstract]

18. Ventura-Clapier R, Kuznetsov AV, d'Albis A, van Deursen J, Wieringa B, Veksler VI. Muscle creatine kinase-deficient mice, 1: alterations in myofibrillar function. J Biol Chem. 1995;270:19914–19920.[Abstract/Free Full Text]

19. Veksler VI, Kuznetsov AV, Anflous K, Mateo P, van Deursen J, Wieringa B, Ventura-Clapier R. Muscle creatine kinase-deficient mice, 2: cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. J Biol Chem. 1995;270:19921–19929.[Abstract/Free Full Text]

20. Srere PA. Citrate synthase. Methods Enzymol. 1969;13:3–11.

21. d'Albis A, Pantaloni C, Béchet JJ. An electrophoretic study of native myosin isoenzymes and their subunit content. Eur J Biochem. 1979;99:261–272.[Medline] [Order article via Infotrieve]

22. d'Albis A, Couteaux R, Janmot C, Roulet A. Specific programs of myosin expression in the postnatal development of rat muscles. Eur J Biochem. 1989;183:583–590.[Medline] [Order article via Infotrieve]

23. Steeghs K, Heerschap A, deHaan A, Ruitenbeek W, Oerlemans F, vanDeursen J, Perryman B, Pette D, Bruckwilder M, Koudijs J, Jap P, Wieringa B. Use of gene targeting for compromising energy homeostasis in neuro-muscular tissues: the role of sarcomeric mitochondrial creatine kinase. J Neurosci Methods. 1997;71:29–41.[Medline] [Order article via Infotrieve]

24. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta. 1987;892:191–196.[Medline] [Order article via Infotrieve]

25. Saks VA, Khuchua ZA, Kuznetsov AV, Veksler VI, Sharov VG. Heart mitochondria in physiological salt solution: not ionic strength but salt composition is important for association of creatine kinase with the inner membrane surface. Biochem Biophys Res Commun. 1986;139:1262–1271.[Medline] [Order article via Infotrieve]

26. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 1988;157:378–417.[Medline] [Order article via Infotrieve]

27. Ventura-Clapier R, Mekhfi H, Vassort G. Role of creatine kinase in force development in chemically skinned rat cardiac muscle. J Gen Physiol. 1987;89:815–837.[Abstract/Free Full Text]

28. Tian R, Nascimben L, Kaddurah-Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996;28:755–765.[Medline] [Order article via Infotrieve]

29. Schultz D, Su XF, Bishop SP, Billadello J, Dell'Italia LJ. Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affected by ACE-inhibitor therapy. J Mol Cell Cardiol. 1997;29:2665–2673.[Medline] [Order article via Infotrieve]

30. Hoang CD, Zhang JY, Payne RM, Apple FS. Postinfarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium. Am J Pathol. 1997;151:257–264.[Abstract]

31. Neubauer S, Frank M, Hu K, Remkes H, Laser A, Horn M, Ertl G, Lohse MJ. Changes of creatine kinase gene expression in rat heart post-myocardial infarction. J Mol Cell Cardiol. 1998;30:803–810.[Medline] [Order article via Infotrieve]

32. Williams RE, Kass DA, Kawagoe Y, Pak P, Tunin RS, Shah R, Hwang A, Feldman AM. Endomyocardial gene expression during development of pacing tachycardia-induced heart failure in the dog. Circ Res. 1994;75:615–623.[Abstract/Free Full Text]

33. Laser A, Neubauer S, Tian R, Hu K, Gaudron P, Ingwall JS, Ertl G. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. J Am Coll Cardiol. 1996;27:487–493.[Abstract]

34. Veksler V, Ventura-Clapier R. In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies. Mol Cell Biochem. 1994;133:287–298.

35. Khuchua ZA, Vasilieva EV, Clark JF, Korchazhkina OV, Branishe T, Kapelko VI, Kuznetsov AV, Ventura-Clapier R, Steinschneider AY, Lakomkin VL, Ruuge EK, Saks VA. The creatine kinase system and cardiomyopathy. Am J Cardiovasc Pathol. 1992;4:223–234.[Medline] [Order article via Infotrieve]

36. Molkentin JD, Lu J-R, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215–228.[Medline] [Order article via Infotrieve]

37. Ventura-Clapier R, Mekhfi H, Oliviero P, Swynghedauw B. Pressure overload changes cardiac skinned fiber mechanics in rat, not in guinea pig. Am J Physiol. 1988;254:H517–H524.[Abstract/Free Full Text]

38. Baudet S, Ventura-Clapier R. Differential effects of caffeine on skinned fibers from control and hypertrophied ferret hearts. Am J Physiol. 1990;259:H1908–H1808.

39. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev. 1986;66:710–771.[Abstract/Free Full Text]

40. Hasenfuss G, Mulieri LA, Holubarsch C, Blanchard EM, Just H, Alpert NR. Myocardial adaptation to stress from the viewpoint of adaptation and development. Basic Res Cardiol. 1993;88:91–102.

41. Mootha VK, Arai AE, Balaban RS. Maximum oxidative phosphorylation capacity of the mammalian heart. Am J Physiol. 1997;41:H769–H775.

42. Laterveer FD, Nicolay K, Gellerich FN. ADP delivery from adenylate kinase in the mitochondrial intermembrane space to oxidative phosphorylation increases in the presence of macromolecules. FEBS Lett. 1996;386:255–259.[Medline] [Order article via Infotrieve]

43. Brdiczka D, Wallimann T. The importance of the outer mitochondrial compartment in regulation of energy metabolism. Mol Cell Biochem. 1994;133:69–83.

44. Saks V, Dos Santos P, Gellerich FN, Diolez P. Quantitative studies of enzyme-substrate compartmentation, functional coupling and metabolic channeling in muscle cells. Mol Cell Biochem. 1998;184:291–307.[Medline] [Order article via Infotrieve]

45. Dzeja PP, Zeleznikar RJ, Goldberg ND. Adenylate kinase: kinetic behaviour in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem. 1998;184:169–182.[Medline] [Order article via Infotrieve]

46. Steeghs K, Benders A, Oerlemans F, deHaan A, Heerschap A, Ruitenbeek W, Jost C, van Deursen J, Perryman B, Pette D, Bruckwilder M, Koudijs J, Jap P, Veerkamp J, Wieringa B. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell. 1997;89:93–103.[Medline] [Order article via Infotrieve]

47. Tian R, Halow JM, Meyer M, Dillmann WH, Figueredo VM, Ingwall JS, Camacho SA. Thermodynamic limitation for Ca2+ handling contributes to decreased contractile reserve in rat hearts. Am J Physiol. 1998;275:H2064–H2071.[Abstract/Free Full Text]

48. Zhang J, Wilke N, Wang Y, Zhang Y, Wang CS, Eijgelshoven MHJ, Cho YK, Murakami Y, Ugurbil K, Bache RJ, From AH. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model: MRI and 31P MRS study. Circulation. 1996;94:1089–1100.[Abstract/Free Full Text]

49. O'Brien PJ, Gwathmey JK. Myocardial Ca2+- and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovasc Res. 1995;30:394–404.[Medline] [Order article via Infotrieve]

50. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70–76.[Abstract/Free Full Text]

51. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res. 1992;70:1225–1232.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. S. Ingwall
Energy metabolism in heart failure and remodelling
Cardiovasc Res, February 15, 2009; 81(3): 412 - 419.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. J. R. Hickey, C. C. Chai, S. Y. Choong, S. de Freitas Costa, G. L. Skea, A. R. J. Phillips, and G. J. S. Cooper
Impaired ATP turnover and ADP supply depress cardiac mitochondrial respiration and elevate superoxide in nonfailing spontaneously hypertensive rat hearts
Am J Physiol Cell Physiol, January 1, 2009; 297(3): C766 - C774.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. Joubert, J. R. Wilding, D. Fortin, V. Domergue-Dupont, M. Novotova, R. Ventura-Clapier, and V. Veksler
Local energetic regulation of sarcoplasmic and myosin ATPase is differently impaired in rats with heart failure
J. Physiol., November 1, 2008; 586(21): 5181 - 5192.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Ciobotaru, M. Heimburger, L. Louedec, C. Heymes, R. Ventura-Clapier, P. Bedossa, B. Escoubet, J.-B. Michel, J.-J. Mercadier, and D. Logeart
Effect of Long-Term Heart Rate Reduction by If Current Inhibition on Pressure Overload-Induced Heart Failure in Rats
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J. Kemi, M. A. Hoydal, P. M. Haram, A. Garnier, D. Fortin, R. Ventura-Clapier, and O. Ellingsen
Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan
Cardiovasc Res, October 1, 2007; 76(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Brixius, R. Lu, B. Boelck, S. Grafweg, F. Hoyer, C. Pott, U. Mehlhorn, W. Bloch, and R. H. G. Schwinger
Chronic Treatment with Carvedilol Improves Ca2+-Dependent ATP Consumption in Triton X-Skinned Fiber Preparations of Human Myocardium
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Neubauer
The Failing Heart -- An Engine Out of Fuel
N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151.
[Full Text] [PDF]


Home page
DiabetesHome page
Y. Athea, B. Viollet, P. Mateo, D. Rousseau, M. Novotova, A. Garnier, S. Vaulont, J. R. Wilding, A. Grynberg, V. Veksler, et al.
AMP-Activated Protein Kinase {alpha}2 Deficiency Affects Cardiac Cardiolipin Homeostasis and Mitochondrial Function
Diabetes, March 1, 2007; 56(3): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. A. Callahan and G. S. Supinski
Diaphragm and cardiac mitochondrial creatine kinases are impaired in sepsis
J Appl Physiol, January 1, 2007; 102(1): 44 - 53.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Ventura-Clapier, B. Mettauer, and X. Bigard
Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure
Cardiovasc Res, January 1, 2007; 73(1): 10 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. R. Wilding, F. Joubert, C. de Araujo, D. Fortin, M. Novotova, V. Veksler, and R. Ventura-Clapier
Altered energy transfer from mitochondria to sarcoplasmic reticulum after cytoarchitectural perturbations in mice hearts
J. Physiol., August 15, 2006; 575(1): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Zoll, L. Monassier, A. Garnier, B. N'Guessan, B. Mettauer, V. Veksler, F. Piquard, R. Ventura-Clapier, and B. Geny
ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction
J Appl Physiol, August 1, 2006; 101(2): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Eimre, R. Puhke, K. Alev, E. Seppet, A. Sikkut, N. Peet, L. Kadaja, A. Lenzner, T. Haviko, T. Seene, et al.
Altered mitochondrial apparent affinity for ADP and impaired function of mitochondrial creatine kinase in gluteus medius of patients with hip osteoarthritis
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1271 - R1275.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Parlakian, C. Charvet, B. Escoubet, M. Mericskay, J. D. Molkentin, G. Gary-Bobo, L. J. De Windt, M.-A. Ludosky, D. Paulin, D. Daegelen, et al.
Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart
Circulation, November 8, 2005; 112(19): 2930 - 2939.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk
Myocardial Substrate Metabolism in the Normal and Failing Heart
Physiol Rev, July 1, 2005; 85(3): 1093 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Helies-Toussaint, C. Moinard, C. Rasmusen, I. Tabbi-Anneni, L. Cynober, and A. Grynberg
Aortic banding in rat as a model to investigate malnutrition associated with heart failure
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1325 - R1331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Burelle, R. B. Wambolt, M. Grist, H. L. Parsons, J. C. F. Chow, C. Antler, A. Bonen, A. Keller, G. A. Dunaway, K. M. Popov, et al.
Regular exercise is associated with a protective metabolic phenotype in the rat heart
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1055 - H1063.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Momken, P. Lechene, R. Ventura-Clapier, and V. Veksler
Voluntary physical activity alterations in endothelial nitric oxide synthase knockout mice
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H914 - H920.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. S. Ingwall and R. G. Weiss
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Circ. Res., July 23, 2004; 95(2): 135 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Ventura-Clapier, A. Garnier, and V. Veksler
Energy metabolism in heart failure
J. Physiol., February 15, 2004; 555(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A Garnier, D Fortin, C Delomenie, I Momken, V Veksler, and R Ventura-Clapier
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
J. Physiol., September 1, 2003; 551(2): 491 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Gong, J. Liu, P. Liang, T. Guo, Q. Hu, K. Ochiai, M. Hou, Y. Ye, X. Wu, A. Mansoor, et al.
Oxidative capacity in failing hearts
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H541 - H548.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Zoll, B. N'Guessan, F. Ribera, E. Lampert, D. Fortin, V. Veksler, X. Bigard, B. Geny, J. Lonsdorfer, R. Ventura-Clapier, et al.
Preserved response of mitochondrial function to short-term endurance training in skeletal muscle of heart transplant recipients
J. Am. Coll. Cardiol., July 2, 2003; 42(1): 126 - 132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Ribera, B. N'Guessan, J. Zoll, D. Fortin, B. Serrurier, B. Mettauer, X. Bigard, R. Ventura-Clapier, and E. Lampert
Mitochondrial Electron Transport Chain Function Is Enhanced in Inspiratory Muscles of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Pye, F. Ardeshirpour, A. McCain, D. A. Bellinger, E. Merricks, J. Adams, P. J. Elliott, C. Pien, T. H. Fischer, A. S. Baldwin Jr., et al.
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H919 - H926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. S. Queiroz, Y. Shao, D. A. Berkich, K. F. Lanoue, and F. Ismail-Beigi
Thyroid hormone regulation of cardiac bioenergetics: role of intracellular creatine
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2527 - H2533.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. De Sousa, P. Lechene, D. Fortin, B. N'Guessan, S. Belmadani, X. Bigard, V. Veksler, and R. Ventura-Clapier
Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity
Cardiovasc Res, November 1, 2002; 56(2): 260 - 268.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
R. Ventura-Clapier, E. De Sousa, and V. Veksler
Metabolic Myopathy in Heart Failure
Physiology, October 1, 2002; 17(5): 191 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J Zoll, H Sanchez, B N'Guessan, F Ribera, E Lampert, X Bigard, B Serrurier, D Fortin, B Geny, V Veksler, et al.
Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle
J. Physiol., August 15, 2002; 543(1): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Burelle and P. W. Hochachka
Endurance training induces muscle-specific changes in mitochondrial function in skinned muscle fibers
J Appl Physiol, June 1, 2002; 92(6): 2429 - 2438.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Joubert, J.-L. Mazet, P. Mateo, and J. A. Hoerter
31P NMR Detection of Subcellular Creatine Kinase Fluxes in the Perfused Rat Heart. CONTRACTILITY MODIFIES ENERGY TRANSFER PATHWAYS
J. Biol. Chem., May 17, 2002; 277(21): 18469 - 18476.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Z. Yang and D. S Steele
Effects of phosphocreatine on SR Ca2+ regulation in isolated saponin-permeabilized rat cardiac myocytes
J. Physiol., March 15, 2002; 539(3): 767 - 777.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Mettauer, J. Zoll, H. Sanchez, E. Lampert, F. Ribera, V. Veksler, X. Bigard, P. Mateo, E. Epailly, J. Lonsdorfer, et al.
Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 947 - 954.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, C. Wang, Y. Murakami, G. Gong, Y. Ishibashi, C. Prody, K. Ochiai, R. J. Bache, C. Godinot, and J. Zhang
Mitochondrial ATPase and high-energy phosphates in failing hearts
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1319 - H1326.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Mihm, F. Yu, C. A. Carnes, P. J. Reiser, P. M. McCarthy, D. R. Van Wagoner, and J. A. Bauer
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation
Circulation, July 10, 2001; 104(2): 174 - 180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ye, C. Wang, J. Zhang, Y. K. Cho, G. Gong, Y. Murakami, and R. J. Bache
Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H376 - H386.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Mihm, C. M. Coyle, B. L. Schanbacher, D. M. Weinstein, and J. A. Bauer
Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure
Cardiovasc Res, March 1, 2001; 49(4): 798 - 807.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Marin-Garcia, M. J Goldenthal, and G. W Moe
Mitochondrial pathology in cardiac failure
Cardiovasc Res, January 1, 2001; 49(1): 17 - 26.
[Full Text] [PDF]


Home page
CirculationHome page
G. S. Nelson, R. D. Berger, B. J. Fetics, M. Talbot, J. C. Spinelli, J. M. Hare, and D. A. Kass
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
Circulation, December 19, 2000; 102(25): 3053 - 3059.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. De Sousa, V. Veksler, X. Bigard, P. Mateo, and R. Ventura-Clapier
Heart Failure Affects Mitochondrial but Not Myofibrillar Intrinsic Properties of Skeletal Muscle
Circulation, October 10, 2000; 102(15): 1847 - 1853.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Pucar, P. P. Dzeja, P. Bast, N. Juranic, S. Macura, and A. Terzic
Cellular Energetics in the Preconditioned State. PROTECTIVE ROLE FOR PHOSPHOTRANSFER REACTIONS CAPTURED BY 18O-ASSISTED 31P NMR
J. Biol. Chem., November 21, 2001; 276(48): 44812 - 44819.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Boudina, M. N. Laclau, L. Tariosse, D. Daret, G. Gouverneur, S. Bonoron-Adele, V. A. Saks, and P. Dos Santos
Alteration of mitochondrial function in a model of chronic ischemia in vivo in rat heart
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H821 - H831.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Z. Yang and D. S Steele
Effects of phosphocreatine on SR Ca2+ regulation in isolated saponin-permeabilized rat cardiac myocytes
J. Physiol., March 15, 2002; 539(3): 767 - 777.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Kaasik, V. Veksler, E. Boehm, M. Novotova, A. Minajeva, and R. Ventura-Clapier
Energetic Crosstalk Between Organelles: Architectural Integration of Energy Production and Utilization
Circ. Res., July 20, 2001; 89(2): 153 - 159.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Sousa, E.
Right arrow Articles by Ventura-Clapier, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Sousa, E.
Right arrow Articles by Ventura-Clapier, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Animal models of human disease
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Heart failure - basic studies